Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38727811)

  • 1. Correlation of microscopic tumor extension with tumor microenvironment in esophageal cancer patients.
    Igbo BT; Jentsch C; Linge A; Plesca I; Kuzay Y; Löck S; Kumaravadivel MS; Doms S; Stolz-Kieslich L; Pollack D; Brückmann S; Tittlbach H; Weitz J; Aust D; Apolle R; Schmitz M; Troost EGC
    Strahlenther Onkol; 2024 May; ():. PubMed ID: 38727811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma.
    Igbo BT; Linge A; Frosch S; Suckert T; Stolz-Kieslich L; Löck S; Kumaravadivel MS; Welsch T; Weitz J; Sommer U; Aust D; Troost EGC
    Clin Transl Radiat Oncol; 2022 Sep; 36():106-112. PubMed ID: 35993091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.
    Machiels M; van Montfoort ML; Thuijs NB; van Berge Henegouwen MI; Alderliesten T; Meijer SL; van Hooft JE; Hulshof MCCM
    Radiat Oncol; 2019 Dec; 14(1):219. PubMed ID: 31801574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells.
    Fan Y; Cheng H; Liu Y; Liu S; Lowe S; Li Y; Bentley R; King B; Tuason JPW; Zhou Q; Sun C; Zhang H
    Front Pharmacol; 2022; 13():955984. PubMed ID: 36046821
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Wang Z; Shi Q; Wang Z; Gu Y; Shen Y; Sun M; Deng M; Zhang H; Fang J; Zhang S; Xie F
    Pathol Res Pract; 2011 Aug; 207(8):505-13. PubMed ID: 21802218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data.
    Verrijssen AS; Guillem J; Perez R; Bujko K; Guedj N; Habr-Gama A; Houben R; Goudkade D; Melenhorst J; Buijsen J; Vanneste B; Grabsch HI; Bellezzo M; Paiva Fonseca G; Verhaegen F; Berbee M; Van Limbergen EJ
    Radiother Oncol; 2020 Mar; 144():37-45. PubMed ID: 31710942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Still proliferating CD44
    Klose J; Schmitt A; Pernthaler J; Warschkow R; Büchler MW; Schneider M; Lasitschka F; Tarantino I
    Eur J Surg Oncol; 2021 Aug; 47(8):2078-2086. PubMed ID: 33814238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Esophageal Tumor Motion and Investigation of Different Image-Guided Correction Strategies.
    Voncken FEM; Nakhaee S; Stam B; Wiersema L; Vollenbrock SE; van Dieren JM; van Leerdam ME; Sonke JJ; Aleman BMP; Remeijer P
    Pract Radiat Oncol; 2020; 10(2):84-92. PubMed ID: 31786235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
    Weber M; Ries J; Braun K; Wehrhan F; Distel L; Geppert C; Lutz R; Kesting M; Trumet L
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.
    Sohda M; Ishikawa H; Masuda N; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Sakurai H; Kuwano H
    Int J Cancer; 2004 Jul; 110(6):838-44. PubMed ID: 15170665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.
    Kartini D; Taher A; Panigoro SS; Setiabudy R; Jusman SW; Haryana SM; Abdullah M; Rustamadji P; Purwanto DJ; Sutandyo N; Suroyo I; Siregar BH; Maruli H; Sungkar S
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):12. PubMed ID: 32372215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67.
    Kar K; Ghosh S; Roy AK
    J Lab Physicians; 2021 Mar; 13(1):50-57. PubMed ID: 34054238
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins.
    Ioachim E; Michael M; Salmas M; Michael MM; Stavropoulos NE; Malamou-Mitsi V
    Urol Int; 2006; 77(3):255-63. PubMed ID: 17033215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment.
    Wang X; Ling X; Wang C; Zhang J; Yang Y; Jiang H; Xin Y; Zhang L; Liang H; Fang C; Zheng D; Zhu J; Ma J
    Cancer Immunol Immunother; 2023 Jun; 72(6):1619-1631. PubMed ID: 36583750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: a new prognostic factor for survival in esophageal cancer.
    Muijs C; Smit J; Karrenbeld A; Beukema J; Mul V; van Dam G; Hospers G; Kluin P; Langendijk J; Plukker J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):845-52. PubMed ID: 24411191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol promotes radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.
    Lu YR; Song J; Zhabihula BX; Zhang JR
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10785-10795. PubMed ID: 31858546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
    Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
    Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy.
    Boekhoff MR; Defize IL; Borggreve AS; Takahashi N; van Lier ALHMW; Ruurda JP; van Hillegersberg R; Lagendijk JJW; Mook S; Meijer GJ
    Radiother Oncol; 2020 Jun; 147():1-7. PubMed ID: 32234611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.